Lance Alan Sloan

10 papers · 424 indexed citations

Immediate Impact

53 hit

Sub-graph 1 of 22

GLP-1-based therapies for diabetes, obesity and beyond

2025 Hit

Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake

2025 Hit

2 intermediate papers

GLP-1a: Going beyond Traditional Use

2022

Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment

2012

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Lance Alan Sloan	346	142	118	80	54	10	424
Renate E. van Genugten	324 0.9×	112 0.8×	111 0.9×	45 0.6×	42 0.8×	14	428
Yoshiharu Horie	238 0.7×	77 0.5×	105 0.9×	101 1.3×	51 0.9×	18	420
Barry Koplowitz	196 0.6×	103 0.7×	125 1.1×	83 1.0×	45 0.8×	14	404
Ryoko Takei	199 0.6×	110 0.8×	177 1.5×	26 0.3×	35 0.6×	9	495
Sudipta Bhattacharya	391 1.1×	132 0.9×	168 1.4×	123 1.5×	67 1.2×	12	469
Mary F. Carroll	196 0.6×	97 0.7×	81 0.7×	68 0.8×	24 0.4×	8	458
Magnus F.G. Grøndahl	352 1.0×	207 1.5×	169 1.4×	15 0.2×	48 0.9×	13	417
Chiaki Kuriyama	343 1.0×	267 1.9×	178 1.5×	37 0.5×	32 0.6×	12	463
Nancy J. Patton	146 0.4×	160 1.1×	189 1.6×	54 0.7×	38 0.7×	10	495
Toshikazu Kigoshi	232 0.7×	126 0.9×	72 0.6×	21 0.3×	40 0.7×	15	440

Loading papers...